Odatroltide demonstrated potential in reperfusion-ineligible AIS patients, who currently face significant unmet medical needs.

It Takes a Village! Navigating the Challenges and Opportunities in Immune-Related Adverse Event Management More broadly than this study, several contextual factors need to be considered before simply ...

SAN ANTONIO, Texas — Researchers have made a major breakthrough that could transform IV medications into oral treatments for diseases like brain cancer and Alzheimer’s, potentially revolutionizing how ...

BOSTON, Oct 25 (Reuters) - An injected version of Eisai (4523.T), opens new tab and Biogen's (BIIB.O), opens new tab Alzheimer's drug Leqembi works as well as the current intravenous version at ...

Results from the Phase 3 CheckMate -67T trial will be presented in a late-breaking oral presentation at ASCO GU 2024. 3 Summer "Power Patterns" Are About to Trigger (One With 90% Win Rate) - Get The ...

Taking a pill is the easiest, least invasive way to take medicine, but unfortunately, not all drugs work that way. Now, Stanford scientists have found “an embarrassingly simple solution” that could ...

Spray-dried protein microparticles without MoNi surfactant form paste-like materials (left), whereas those spray dried with MoNi surfactant form injectable suspensions that flow like liquids (right).

To date, the Company has not received any reports of adverse events related to this recall. Leiters Health is voluntarily recalling 33 lots of vancomycin intravenous (IV) bags, phenylephrine IV bags, ...